Looks as though the .60c barrier might be a hurdle this time up also.No doubt some of the new holders from yesterday taking some profits.Once it gets through though hopefully as screenjockey posted it will move up quickly with plenty of gaps D
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%